Question 1

Is Ipratropiumbromid (Ph.Eur.) currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Ipratropiumbromid (Ph.Eur.) has 14 active shortage notices across 5 countries (Germany, New Zealand, Netherlands, Canada, Ireland). Status is refreshed daily from official regulatory sources.

Question 2

Why is Ipratropiumbromid (Ph.Eur.) in shortage?

Accepted Answer

Regulators attribute the current Ipratropiumbromid (Ph.Eur.) shortages to manufacturing problems, supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Ipratropiumbromid (Ph.Eur.) shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 31 Mar 2026 to 31 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Ipratropiumbromid (Ph.Eur.) shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Germany	high	5	17 Apr 2023	31 Oct 2026	BfArM
New Zealand	high	1	27 Mar 2026	—	Pharmac

Ipratropiumbromid (Ph.Eur.) shortage status

Where Ipratropiumbromid (Ph.Eur.) is in shortage

Why Ipratropiumbromid (Ph.Eur.) is in shortage

Frequently asked questions

Get alerted when Ipratropiumbromid (Ph.Eur.) status changes